XML 74 R63.htm IDEA: XBRL DOCUMENT v3.19.2
Condensed Consolidating Financial Statements of Aramark and Subsidiaries - Statements of Income And Comprehensive Income (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Jun. 28, 2019
Jun. 29, 2018
Jun. 28, 2019
Jun. 29, 2018
Condensed Financial Statements, Captions [Line Items]        
Revenue $ 4,010,761 $ 3,971,606 $ 12,276,097 $ 11,876,035
Cost of services provided 3,594,978 3,526,293 11,029,382 10,611,532
Costs and Expenses:        
Depreciation and amortization 148,779 156,934 447,408 443,646
Selling and general corporate expenses 78,185 101,715 270,600 282,327
Gain on sale of Healthcare Technologies     (156,309) 0
Interest and other financing costs, net 82,220 89,776 249,375 256,562
Expense allocations 0 0 0 0
Total Costs and Expenses 3,904,162 3,874,718 11,840,456 11,594,067
Income (Loss) before Income Tax 106,599 96,888 435,641 281,968
Provision (Benefit) for Income Taxes 23,535 24,172 72,589 (110,904)
Equity in Net Income of Subsidiaries 0 0 0 0
Net income 83,064 72,716 363,052 392,872
Less: Net income attributable to noncontrolling interest 109 139 60 442
Net income attributable to Aramark stockholders 82,955 72,577 362,992 392,430
Other comprehensive income (loss), net of tax (29,187) (35,371) (79,615) 25,694
Comprehensive income attributable to Aramark stockholders 53,768 37,206 283,377 418,124
Eliminations        
Condensed Financial Statements, Captions [Line Items]        
Revenue 0 0 0 0
Cost of services provided 0 0 0 0
Costs and Expenses:        
Depreciation and amortization 0 0 0 0
Selling and general corporate expenses 0 0 0 0
Gain on sale of Healthcare Technologies     0  
Interest and other financing costs, net 0 0 0 0
Expense allocations 0 0 0 0
Total Costs and Expenses 0 0 0 0
Income (Loss) before Income Tax 0 0 0 0
Provision (Benefit) for Income Taxes 0 0 0 0
Equity in Net Income of Subsidiaries (82,955) (72,577) (362,992) (392,430)
Net income (82,955) (72,577) (362,992) (392,430)
Less: Net income attributable to noncontrolling interest 0 0 0 0
Net income attributable to Aramark stockholders (82,955) (72,577) (362,992) (392,430)
Other comprehensive income (loss), net of tax 10,002 87,215 105,268 (4,666)
Comprehensive income attributable to Aramark stockholders (72,953) 14,638 (257,724) (397,096)
Aramark (Parent) | Reportable Legal Entities        
Condensed Financial Statements, Captions [Line Items]        
Revenue 0 0 0 0
Cost of services provided 0 0 0 0
Costs and Expenses:        
Depreciation and amortization 0 0 0 0
Selling and general corporate expenses 0 0 0 0
Gain on sale of Healthcare Technologies     0  
Interest and other financing costs, net 0 0 0 0
Expense allocations 0 0 0 0
Total Costs and Expenses 0 0 0 0
Income (Loss) before Income Tax 0 0 0 0
Provision (Benefit) for Income Taxes 0 0 0 0
Equity in Net Income of Subsidiaries 82,955 72,577 362,992 392,430
Net income 82,955 72,577 362,992 392,430
Less: Net income attributable to noncontrolling interest 0 0 0 0
Net income attributable to Aramark stockholders 82,955 72,577 362,992 392,430
Other comprehensive income (loss), net of tax (29,187) (35,371) (79,615) 25,694
Comprehensive income attributable to Aramark stockholders 53,768 37,206 283,377 418,124
Issuers | Reportable Legal Entities        
Condensed Financial Statements, Captions [Line Items]        
Revenue 271,186 261,383 799,765 772,008
Cost of services provided 257,515 235,789 738,608 681,761
Costs and Expenses:        
Depreciation and amortization 4,090 4,771 12,379 14,645
Selling and general corporate expenses 26,038 51,310 117,650 153,434
Gain on sale of Healthcare Technologies     0  
Interest and other financing costs, net 77,896 85,080 234,808 244,475
Expense allocations (70,854) (77,642) (215,792) (223,650)
Total Costs and Expenses 294,685 299,308 887,653 870,665
Income (Loss) before Income Tax (23,499) (37,925) (87,888) (98,657)
Provision (Benefit) for Income Taxes (6,381) (9,612) (33,398) (37,516)
Equity in Net Income of Subsidiaries 0 0 0 0
Net income (17,118) (28,313) (54,490) (61,141)
Less: Net income attributable to noncontrolling interest 0 0 0 0
Net income attributable to Aramark stockholders (17,118) (28,313) (54,490) (61,141)
Other comprehensive income (loss), net of tax (30,062) 13,521 (74,487) 36,344
Comprehensive income attributable to Aramark stockholders (47,180) (14,792) (128,977) (24,797)
Guarantors | Reportable Legal Entities        
Condensed Financial Statements, Captions [Line Items]        
Revenue 2,589,449 2,580,276 8,067,783 7,828,692
Cost of services provided 2,285,548 2,262,103 7,125,488 6,889,070
Costs and Expenses:        
Depreciation and amortization 119,529 127,321 358,772 360,485
Selling and general corporate expenses 44,838 43,179 131,764 111,383
Gain on sale of Healthcare Technologies     (156,309)  
Interest and other financing costs, net 532 (330) 2,539 207
Expense allocations 67,384 73,564 203,680 210,863
Total Costs and Expenses 2,517,831 2,505,837 7,665,934 7,572,008
Income (Loss) before Income Tax 71,618 74,439 401,849 256,684
Provision (Benefit) for Income Taxes 15,406 17,470 75,704 (112,920)
Equity in Net Income of Subsidiaries 0 0 0 0
Net income 56,212 56,969 326,145 369,604
Less: Net income attributable to noncontrolling interest 109 139 60 442
Net income attributable to Aramark stockholders 56,103 56,830 326,085 369,162
Other comprehensive income (loss), net of tax 0 0 0 2,181
Comprehensive income attributable to Aramark stockholders 56,103 56,830 326,085 371,343
Non Guarantors | Reportable Legal Entities        
Condensed Financial Statements, Captions [Line Items]        
Revenue 1,150,126 1,129,947 3,408,549 3,275,335
Cost of services provided 1,051,915 1,028,401 3,165,286 3,040,701
Costs and Expenses:        
Depreciation and amortization 25,160 24,842 76,257 68,516
Selling and general corporate expenses 7,309 7,226 21,186 17,510
Gain on sale of Healthcare Technologies     0  
Interest and other financing costs, net 3,792 5,026 12,028 11,880
Expense allocations 3,470 4,078 12,112 12,787
Total Costs and Expenses 1,091,646 1,069,573 3,286,869 3,151,394
Income (Loss) before Income Tax 58,480 60,374 121,680 123,941
Provision (Benefit) for Income Taxes 14,510 16,314 30,283 39,532
Equity in Net Income of Subsidiaries 0 0 0 0
Net income 43,970 44,060 91,397 84,409
Less: Net income attributable to noncontrolling interest 0 0 0 0
Net income attributable to Aramark stockholders 43,970 44,060 91,397 84,409
Other comprehensive income (loss), net of tax 20,060 (100,736) (30,781) (33,859)
Comprehensive income attributable to Aramark stockholders $ 64,030 $ (56,676) $ 60,616 $ 50,550